Current Status of Pharmacogenomics Testing for Anti-Tumor Drug Therapies: Approaches to Non-Melanoma Skin Cancer

Author： Grealy Rebecca   Griffiths Lyn R.  

Publisher： Adis International

ISSN： 1177-1062

Source： Molecular Diagnosis & Therapy, Vol.13, Iss.2, 2009-04, pp. : 65-72

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Validation of THIN data for non-melanoma skin cancer

By Meal Andy   Leonardi-Bee Jo   Smith Chris   Hubbard Richard   Bath-Hextall Fiona  

Quality in Primary Care, Vol. 16, Iss. 1, 2008-02 ,pp. : 49-52

Radcliffe Press

Access to resources Recommend Favorite

Quality of life in non‐melanoma skin cancer

By  

AUSTRALASIAN JOURNAL OF DERMATOLOGY, Vol. 56, Iss. 1, 2015-02 ,pp. : 70-76

John Wiley & Sons Inc

Access to resources Recommend Favorite

Th17 cytokines in non‐melanoma skin cancer

By  

EUROPEAN JOURNAL OF IMMUNOLOGY, Vol. 45, Iss. 3, 2015-03 ,pp. : 692-694

John Wiley & Sons Inc

Access to resources Recommend Favorite

The collision tumor in the assessment of non‐melanoma skin cancer caused by occupational UV exposure

By  

JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, Vol. 13, Iss. 5, 2015-05 ,pp. : 461-463

John Wiley & Sons Inc

Access to resources Recommend Favorite

Incidence and prevalence of non‐melanoma skin cancer in Australia: A systematic review

By  

AUSTRALASIAN JOURNAL OF DERMATOLOGY, Vol. 56, Iss. 4, 2015-11 ,pp. : 258-267

John Wiley & Sons Inc

Access to resources Recommend Favorite